Spirits sales beat out beer and wine for second straight year, despite little growth

Spirits sales beat out beer and wine for second straight year, despite little growth


Spirits on display at a bar in Cardiff, Wales, in the United Kingdom.

Matthew Horwood | Getty Images News | Getty Images

The spirits industry held its market share edge over beer and wine for the second straight year in 2023, even as it showed little growth, according to new data released Wednesday.

U.S. spirits revenue grew only a modest 0.2% last year to $37.7 billion, according to the Distilled Spirits Council of the U.S.’ annual economic report. Although the industry gained little total revenue, it outpaced beer and wine sales by 0.4% and 26.1%, respectively.

Though high inflation and interest rates have dampened consumer discretionary spending, the beverage alcohol industry has maintained strength as it emerged from the Covid-19 pandemic boom, said Chris Swonger, president and CEO of DISCUS.

“The spirits sector showed resilience in 2023, navigating through the choppy wake of the pandemic and maintaining our market share lead of the total beverage alcohol market,” said Swonger. “The phenomenal sales growth we saw during the pandemic was unprecedented and unpredictable but also unsustainable, and now, the spirits market is recalibrating.”

Vodka remained the top-selling spirit in 2023, while the second-highest selling category, tequila and mezcal, gained even more of a lead on American whiskey. Tequila and mezcal, blended whiskey and American whiskey are among the fastest-growing spirits categories by revenue.

Swonger also was optimistic about the spirits industry’s strategy to push consumers to pricier bottles and labels, despite the weakness reported this quarter by premium spirits makers such as Diageo, LVMH and Constellation Brands.

During the Covid-19 pandemic, consumers in quarantine sought out higher-quality spirits. Since peak growth in 2021, luxury spirits sales have started to dwindle.

Diageo shares plummeted in November when the European spirits giant cut guidance on an expected slowdown in growth for the first half of its fiscal year. Premium spirits and wine weakness also hit LVMH in 2023. It was the company’s only business segment to report a year-over-year organic revenue decline, down 4%.

Though some parts of the industry have weakened, the rapid rise of ready-to-drink cocktails has been a bright spot for investors.

Premixed cocktails were the fastest-growing spirits category last year, rising 26.7% to $2.8 billion in revenue, DISCUS reported.

“Despite the hard seltzer craze we witnessed from 2017 to 2021 which was malt-driven, spirits-based products have actually grown faster, just off a smaller base,” said Marten Lodewijks, head of consulting at IWSR, a drinks market analysis firm. “Spirits-based products, including the vodka- and tequila-based hard seltzers that entered the picture later, offer consumers a slightly more premium experience, and that has been key to their success.”

More beverage companies have gotten into the market. Coca-Cola launched its ready-to-drink cocktail with Brown-Forman‘s Jack Daniel’s whiskey in 2022.

During another year of growth, American whiskey got more good news in 2023. The U.S. and European Union reached an agreement to extend a suspension of EU tariffs on the liquor to March 31, 2025.

Correction: This story was updated to reflect that Brown-Forman owns Jack Daniel’s whiskey.

Don’t miss these stories from CNBC PRO:



Source

Nike cuts 1,400 roles in second round of layoffs this year
Business

Nike cuts 1,400 roles in second round of layoffs this year

People walk past a Nike store in New York City, on April 2, 2025. Kylie Cooper | Reuters Nike announced a new round of layoffs on Thursday impacting approximately 1,400 roles across the organization, mostly concentrated in its technology department. In a note from COO Venkatesh Alagirisamy, the company said the layoffs were part of […]

Read More
Trump administration moves to reclassify cannabis in major shift that could expand research
Business

Trump administration moves to reclassify cannabis in major shift that could expand research

The Trump administration moved Thursday to reclassify cannabis under federal law, which could significantly expand scientific research into the drug’s medical uses. The change would not legalize the drug at the federal level, but shift cannabis from its current status as a Schedule I substance to Schedule III under the U.S. Drug Enforcement Administration’s controlled […]

Read More
Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free
Business

Regeneron inks drug pricing deal with Trump, will offer new hearing-loss therapy for free

U.S. President Donald Trump (C) speaks during an event on advancing health care affordability in the Oval Office of the White House on April 23, 2026 in Washington, DC. Alex Wong | Getty Images Regeneron agreed to lower U.S. drug prices for some Americans as part of a deal with President Donald Trump, the White […]

Read More